These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26020027)

  • 21. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.
    Takeyama N; Mizobuchi N; Sakaki M; Shimozuma Y; Munechika J; Kajiwara A; Uchikoshi M; Uozumi S; Ohgiya Y; Gokan T
    Abdom Radiol (NY); 2019 Mar; 44(3):923-935. PubMed ID: 30327828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.
    Sheng RF; Zeng MS; Ren ZG; Ye SL; Zhang L; Chen CZ
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):603-12. PubMed ID: 26663008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
    Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software.
    Hendriks P; Noortman WA; Baetens TR; van Erkel AR; van Rijswijk CSP; van der Meer RW; Coenraad MJ; de Geus-Oei LF; Slump CH; Burgmans MC
    J Oncol; 2019; 2019():4049287. PubMed ID: 31641353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability.
    Minami Y; Minami T; Takita M; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
    Hepatol Res; 2020 Jan; 50(1):67-74. PubMed ID: 31301213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy.
    Sakakibara M; Ohkawa K; Katayama K; Imanaka K; Ishihara A; Hasegawa N; Kimura H
    AJR Am J Roentgenol; 2014 May; 202(5):W487-95. PubMed ID: 24758684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
    Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
    Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
    Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
    Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration.
    Minami Y; Minami T; Ueshima K; Yagyu Y; Tsurusaki M; Okada T; Hori M; Kudo M; Murakami T
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study.
    Li FY; Li JG; Wu SS; Ye HL; He XQ; Zeng QJ; Zheng RQ; An C; Li K
    J Hepatocell Carcinoma; 2021; 8():1375-1388. PubMed ID: 34815974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial.
    Liao M; Zhong X; Zhang J; Liu Y; Zhu Z; Wu H; Zeng Y; Huang J
    J Surg Oncol; 2017 Jun; 115(8):971-979. PubMed ID: 28334430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases.
    Minami Y; Minami T; Chishina H; Kono M; Arizumi T; Takita M; Yada N; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
    Dig Dis; 2016; 34(6):687-691. PubMed ID: 27750238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Najafi A; de Baere T; Purenne E; Bayar A; Al Ahmar M; Delpla A; Roux C; Madani K; Assouline J; Deschamps F; Tselikas L
    Eur Radiol; 2021 Jul; 31(7):5361-5369. PubMed ID: 33474569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma.
    Siriapisith T; Siwasattayanon P; Tongdee T
    J Med Assoc Thai; 2012 Mar; 95(3):430-6. PubMed ID: 22550844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
    Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
    J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching Monopolar No-Touch Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma: A Randomized Clinical Trial.
    Park SJ; Cho EJ; Lee JH; Yu SJ; Kim YJ; Yoon JH; Kang HJ; Yoon JH; Lee DH; Kim SH; Lee JY; Lee JM
    Liver Cancer; 2021 Feb; 10(1):72-81. PubMed ID: 33708641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the Ablative Margin on Local Tumor Progression after Radiofrequency Ablation for Lung Metastases from Colorectal Carcinoma: Supplementary Analysis of a Phase II Trial (MLCSG-0802).
    Hasegawa T; Takaki H; Kodama H; Matsuo K; Yamanaka T; Nakatsuka A; Takao M; Gobara H; Hayashi S; Inaba Y; Yamakado K
    J Vasc Interv Radiol; 2023 Jan; 34(1):31-37.e1. PubMed ID: 36209996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.